Calidi Biotherapeutics, Inc. (CLDI)

USD 1.44

(-16.76%)

Revenue Summary of Calidi Biotherapeutics, Inc.

  • Calidi Biotherapeutics, Inc.'s latest annual revenue in 2023 was - USD , down -100.0% from previous year.
  • Calidi Biotherapeutics, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Calidi Biotherapeutics, Inc. reported a annual revenue of 45 Thousand USD in annual revenue 2022, down -89.98% from previous year.
  • Calidi Biotherapeutics, Inc. reported a annual revenue of 449 Thousand USD in annual revenue 2021, down 0.0% from previous year.
  • Calidi Biotherapeutics, Inc. reported a quarterly revenue of - USD for 2024 Q1, down 0.0% from previous quarter.
  • Calidi Biotherapeutics, Inc. reported a quarterly revenue of - USD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Calidi Biotherapeutics, Inc. (2023 - 2020)

Historical Annual Revenue of Calidi Biotherapeutics, Inc. (2023 - 2020)

Year Revenue Revenue Growth
2023 - USD -100.0%
2022 45 Thousand USD -89.98%
2021 449 Thousand USD 0.0%
2020 - USD 0.0%

Peer Revenue Comparison of Calidi Biotherapeutics, Inc.

Name Revenue Revenue Difference
AIM ImmunoTech Inc. 202 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. - USD NaN%
Armata Pharmaceuticals, Inc. 4.52 Million USD 100.0%
Actinium Pharmaceuticals, Inc. 81 Thousand USD 100.0%
Azitra, Inc. 686 Thousand USD 100.0%
Can-Fite BioPharma Ltd. 743 Thousand USD 100.0%
Chromocell Therapeutics Corporation - USD NaN%
CEL-SCI Corporation - USD NaN%
iBio, Inc. 225 Thousand USD 100.0%
Lineage Cell Therapeutics, Inc. 8.94 Million USD 100.0%
MAIA Biotechnology, Inc. - USD NaN%
Matinas BioPharma Holdings, Inc. 1.09 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD 100.0%
NovaBay Pharmaceuticals, Inc. 14.72 Million USD 100.0%
NanoViricides, Inc. - USD NaN%
Oragenics, Inc. 37.65 Thousand USD 100.0%
BiomX Inc. -357 Thousand USD 100.0%
BiomX Inc. -357 Thousand USD 100.0%
Protalix BioTherapeutics, Inc. 65.49 Million USD 100.0%
Palatin Technologies, Inc. 4.49 Million USD 100.0%
Scorpius Holdings, Inc. 6.99 Million USD 100.0%